1
|
Mpangala KR, Halasa-Rappel YA, Mohamed MS, Mnzava RC, Mkuza KJ, Mangesho PE, Kisinza WN, Mugasa JP, Messenger LA, Mtove G, Kihombo AR, Shepard DS. On the cost-effectiveness of insecticide-treated wall liner and indoor residual spraying as additions to insecticide treated bed nets to prevent malaria: findings from cluster randomized trials in Tanzania. BMC Public Health 2021; 21:1666. [PMID: 34521374 PMCID: PMC8439046 DOI: 10.1186/s12889-021-11671-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Accepted: 08/11/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Despite widespread use of long-lasting insecticidal nets (LLINs) and other tools, malaria caused 409,000 deaths worldwide in 2019. While indoor residual spraying (IRS) is an effective supplement, IRS is moderately expensive and logistically challenging. In endemic areas, IRS requires yearly application just before the main rainy season and potential interim reapplications. A new technology, insecticide-treated wall liner (ITWL), might overcome these challenges. METHODS We conducted a 44-cluster two-arm randomized controlled trial in Muheza, Tanzania from 2015 to 2016 to evaluate the cost and efficacy of a non-pyrethroid ITWL to supplement LLINs, analyzing operational changes over three installation phases. The estimated efficacy (with 95% confidence intervals) of IRS as a supplement to LLINs came mainly from a published randomized trial in Muleba, Tanzania. We obtained financial costs of IRS from published reports and conducted a household survey of a similar IRS program near Muleba to determine household costs. The costs of ITWL were amortized over its 4-year expected lifetime and converted to 2019 US dollars using Tanzania's GDP deflator and market exchange rates. RESULTS Operational improvements from phases 1 to 3 raised ITWL coverage from 35.1 to 67.1% of initially targeted households while reducing economic cost from $34.18 to $30.56 per person covered. However, 90 days after installing ITWL in 5666 households, the randomized trial was terminated prematurely because cone bioassay tests showed that ITWL no longer killed mosquitoes and therefore could not prevent malaria. The ITWL cost $10.11 per person per year compared to $5.69 for IRS. With an efficacy of 57% (3-81%), IRS averted 1162 (61-1651) disability-adjusted life years (DALYs) per 100,000 population yearly. Its incremental cost-effectiveness ratio (ICER) per DALY averted was $490 (45% of Tanzania's per capita gross national income). CONCLUSIONS These findings provide design specifications for future ITWL development and implementation. It would need to be efficacious and more effective and/or less costly than IRS, so more persons could be protected with a given budget. The durability of a previous ITWL, progress in non-pyrethroid tools, economies of scale and competition (as occurred with LLINs), strengthened community engagement, and more efficient installation and management procedures all offer promise of achieving these goals. Therefore, ITWLs merit ongoing study. FIRST POSTED 2015 ( NCT02533336 ).
Collapse
Affiliation(s)
- Kihomo Robert Mpangala
- Brandeis University, Waltham, MA, 02453, USA.,Empowered and Improvement Livelihood Initiatives Foundation, Dar es Salaam, Tanzania
| | | | | | - Ruth C Mnzava
- National Institute for Medical Research, Amani Centre, Muheza, Tanzania
| | - Kaseem J Mkuza
- National Institute for Medical Research, Amani Centre, Muheza, Tanzania
| | - Peter E Mangesho
- National Institute for Medical Research, Amani Centre, Muheza, Tanzania
| | - William N Kisinza
- National Institute for Medical Research, Amani Centre, Muheza, Tanzania
| | - Joseph P Mugasa
- National Institute for Medical Research, Amani Centre, Muheza, Tanzania.,Population Services International, Dar es Salaam, Tanzania
| | | | - George Mtove
- National Institute for Medical Research, Amani Centre, Muheza, Tanzania
| | - Aggrey R Kihombo
- Brandeis University, Waltham, MA, 02453, USA.,Mzumbe University, Dar es Salaam, Tanzania
| | | |
Collapse
|
2
|
Mishra AK, Bharti PK, Kareemi TI, Chand SK, Tidgam AS, Sharma RK, Singh N. Field evaluation of zero vector durable lining to assess its efficacy against malaria vectors and malaria transmission in tribal areas of the Balaghat district of central India. Trans R Soc Trop Med Hyg 2019; 113:623-631. [PMID: 31251386 DOI: 10.1093/trstmh/trz046] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2018] [Revised: 03/22/2019] [Accepted: 06/20/2019] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Indoor residual spray (IRS) and long-lasting insecticidal nets are the two principal intervention methods of vector control. Zero vector durable lining (ZVDL), a relatively new vector control method, was evaluated to assess its efficacy against malaria vectors in hard to reach areas in the Balaghat district, where malaria transmission is perennial. METHODS ZVDL was installed in six experimental villages during November-December 2012. In control villages, IRS was carried out with Alphacypermethrin. Cone bioassays were performed to assess the efficacy and persistence of insecticide-treated ZVDL following WHO bioassays. RESULTS The mean per man hour density of Anopheles caught during 2013 was 12.1 in experimental villages and 16.2 in control villages. No sporozoite-positive Anopheles culicifacies were found in experimental villages; however, in control villages, four sporozoite-positive A. culicifacies were found (two Plasmodium vivax and two P. falciparum). The knock-down rate of A. culicifacies was 95-100% with 100% mortality during the 24 h recovery period. Malaria declined sharply in experimental villages showing a slide positivity rate of 22.3% compared with control villages (36.4%) (p<0.05). CONCLUSIONS A supplementary vector control intervention such as ZVDL has the potential to become a viable alternative to IRS in malaria endemic areas.
Collapse
Affiliation(s)
- Ashok K Mishra
- National Institute of Research in Tribal Health (NIRTH), Nagpur Road, Garha, Jabalpur, Madhya Pradesh, India
| | - Praveen K Bharti
- National Institute of Research in Tribal Health (NIRTH), Nagpur Road, Garha, Jabalpur, Madhya Pradesh, India
| | - Tazeen Iram Kareemi
- National Institute of Research in Tribal Health (NIRTH), Nagpur Road, Garha, Jabalpur, Madhya Pradesh, India
| | - Sunil K Chand
- National Institute of Malaria Research, Field Unit, Nagpur Road, Garha Jabalpur, Madhya Pradesh, India
| | - Anup Singh Tidgam
- District Malaria Office, Balaghat, District Balaghat, Madhya Pradesh, India
| | - Ravendra K Sharma
- National Institute of Research in Tribal Health (NIRTH), Nagpur Road, Garha, Jabalpur, Madhya Pradesh, India
| | - Neeru Singh
- National Institute of Research in Tribal Health (NIRTH), Nagpur Road, Garha, Jabalpur, Madhya Pradesh, India
| |
Collapse
|
3
|
Chowdhury R, Faria S, Huda MM, Chowdhury V, Maheswary NP, Mondal D, Akhter S, Akter S, Khan RK, Nabi SG, Kroeger A, Argaw D, Alvar J, Dash AP, Banu Q. Control of Phlebotomus argentipes (Diptera: Psychodidae) sand fly in Bangladesh: A cluster randomized controlled trial. PLoS Negl Trop Dis 2017; 11:e0005890. [PMID: 28873425 PMCID: PMC5600390 DOI: 10.1371/journal.pntd.0005890] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2017] [Revised: 09/15/2017] [Accepted: 08/21/2017] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND A number of studies on visceral leishmaniasis (VL) vector control have been conducted during the past decade, sometimes came to very different conclusion. The present study on a large sample investigated different options which are partially unexplored including: (1) indoor residual spraying (IRS) with alpha cypermethrin 5WP; (2) long lasting insecticide impregnated bed-net (LLIN); (3) impregnation of local bed-nets with slow release insecticide K-O TAB 1-2-3 (KOTAB); (4) insecticide spraying in potential breeding sites outside of house using chlorpyrifos 20EC (OUT) and different combinations of the above. METHODS The study was a cluster randomized controlled trial where 3089 houses from 11 villages were divided into 10 sections, each section with 6 clusters and each cluster having approximately 50 houses. Based on vector density (males plus females) during baseline survey, the 60 clusters were categorized into 3 groups: (1) high, (2) medium and (3) low. Each group had 20 clusters. From these three groups, 6 clusters (about 300 households) were randomly selected for each type of intervention and control arms. Vector density was measured before and 2, 4, 5, 7, 11, 14, 15, 18 and 22 months after intervention using CDC light traps. The impact of interventions was measured by using the difference-in-differences regression model. RESULTS A total of 17,434 sand flies were collected at baseline and during the surveys conducted over 9 months following the baseline measurements. At baseline, the average P. argentipes density per household was 10.6 (SD = 11.5) in the control arm and 7.3 (SD = 8.46) to 11.5 (SD = 20.2) in intervention arms. The intervention results presented as the range of percent reductions of sand flies (males plus females) and rate ratios in 9 measurements over 22 months. Among single type interventions, the effect of IRS with 2 rounds of spraying (applied by the research team) ranged from 13% to 75% reduction of P. argentipes density compared to the control arm (rate-ratio [RR] ranged from 0.25 to 0.87). LLINs caused a vector reduction of 9% to 78% (RR, 0.22 to 0.91). KOTAB reduced vectors by 4% to 73% (RR, 0.27 to 0.96). The combination of LLIN and OUT led to a vector reduction of 26% to 86% (RR, 0.14 to 0.74). The reduction for the combination of IRS and OUT was 8% to 88% (RR, 0.12 to 0.92). IRS and LLIN combined resulted in a vector reduction of 13% to 85% (RR, 0.15 to 0.77). The IRS and KOTAB combination reduced vector densities by 16% to 86% (RR, 0.14 to 0.84). Some intermediate measurements for KOTAB alone and for IRS plus LLIN; and IRS plus KOTAB were not statistically significant. The bioassays on sprayed surfaces or netting materials showed favourable results (>80% mortality) for 22 months (IRS tested for 12 months). In the KOTAB, a gradual decline was observed after 6 months. CONCLUSIONS LLIN and OUT was the best combination to reduce VL vector densities for 22 months or longer. Operationally, this is much easier to apply than IRS. A cost analysis of the preferred tools will follow. The relationship between vector density (males plus females) and leishmaniasis incidence should be investigated, and this will require estimates of the Entomological Inoculation Rate.
Collapse
Affiliation(s)
- Rajib Chowdhury
- National Institute of Preventive and Social Medicine (NIPSOM), Mohakhali, Dhaka, Bangladesh
- International Centre for Diarrhoea Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
| | - Shyla Faria
- International Centre for Diarrhoea Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
| | - M. Mamun Huda
- International Centre for Diarrhoea Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
| | | | | | - Dinesh Mondal
- International Centre for Diarrhoea Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
| | - Shireen Akhter
- National Institute of Preventive and Social Medicine (NIPSOM), Mohakhali, Dhaka, Bangladesh
| | - Sakila Akter
- National Institute of Preventive and Social Medicine (NIPSOM), Mohakhali, Dhaka, Bangladesh
| | - Rajaul Karim Khan
- Directorate General of Health Services (DGHS), Mohakhali, Dhaka, Bangladesh
| | | | - Axel Kroeger
- Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
- University of Freiburg, Centre for Medicine and Society/Anthropology, Freiburg, Germany
| | - Daniel Argaw
- World Health Organization (WHO), Geneva, Switzerland
| | - Jorge Alvar
- Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
| | | | - Qamar Banu
- Asian University for Women, Chittatong, Bangladesh
| |
Collapse
|
4
|
Messenger LA, Rowland M. Insecticide-treated durable wall lining (ITWL): future prospects for control of malaria and other vector-borne diseases. Malar J 2017; 16:213. [PMID: 28532494 PMCID: PMC5441104 DOI: 10.1186/s12936-017-1867-z] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Accepted: 05/15/2017] [Indexed: 11/24/2022] Open
Abstract
While long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) are the cornerstones of malaria vector control throughout sub-Saharan Africa, there is an urgent need for the development of novel insecticide delivery mechanisms to sustain and consolidate gains in disease reduction and to transition towards malaria elimination and eradication. Insecticide-treated durable wall lining (ITWL) may represent a new paradigm for malaria control as a potential complementary or alternate longer-lasting intervention to IRS. ITWL can be attached to inner house walls, remain efficacious over multiple years and overcome some of the operational constraints of first-line control strategies, specifically nightly behavioural compliance required of LLINs and re-current costs and user fatigue associated with IRS campaigns. Initial experimental hut trials of insecticide-treated plastic sheeting reported promising results, achieving high levels of vector mortality, deterrence and blood-feeding inhibition, particularly when combined with LLINs. Two generations of commercial ITWL have been manufactured to date containing either pyrethroid or non-pyrethroid formulations. While some Phase III trials of these products have demonstrated reductions in malaria incidence, further large-scale evidence is still required before operational implementation of ITWL can be considered either in a programmatic or more targeted community context. Qualitative studies of ITWL have identified aesthetic value and observable entomological efficacy as key determinants of household acceptability. However, concerns have been raised regarding installation feasibility and anticipated cost-effectiveness. This paper critically reviews ITWL as both a putative mechanism of house improvement or more conventional intervention and discusses its future prospects as a method for controlling malaria and other vector-borne diseases.
Collapse
Affiliation(s)
- Louisa A Messenger
- Department of Disease Control, Faculty of Infectious Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
| | - Mark Rowland
- Department of Disease Control, Faculty of Infectious Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
| |
Collapse
|
5
|
Kuadima JJ, Timinao L, Naidi L, Tandrapah A, Hetzel MW, Czeher C, Pulford J. Long-term acceptability, durability and bio-efficacy of ZeroVector ® durable lining for vector control in Papua New Guinea. Malar J 2017; 16:93. [PMID: 28241875 PMCID: PMC5329951 DOI: 10.1186/s12936-017-1742-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2016] [Accepted: 02/20/2017] [Indexed: 11/10/2022] Open
Abstract
Background This study examined the acceptability, durability and bio-efficacy of pyrethroid-impregnated durable lining (DL) over a three-year period post-installation in residential homes across Papua New Guinea (PNG). Methods ZeroVector® ITPS had previously been installed in 40 homes across four study sites representing a cross section of malaria transmission risk and housing style. Structured questionnaires, DL visual inspections and group interviews (GIs) were completed with household heads at 12- and 36-months post-installation. Three DL samples were collected from all households in which it remained 36-months post-installation to evaluate the bio-efficacy of DL on Anopheles mosquitoes. Bio-efficacy testing followed WHO guidelines for the evaluation of indoor residual spraying. Results The DL was still intact in 86 and 39% of study homes at the two time periods, respectively. In homes in which the DL was still intact, 92% of household heads considered the appearance at 12-months post installation to be the same as, or better than, that at installation compared to 59% at 36-months post-installation. GIs at both time points confirmed continuing high acceptance of DL, based in large part of the perceived attractiveness and functionality of the material. However, participants frequently asserted that they, or their family members, had ceased or reduced their use of mosquito nets as a result of the DL installation. A total of 16 houses were sampled for bio-efficacy testing across the 4 study sites at 36-months post-installation. Overall, combining all sites and samples, both knock-down at 30 min and mortality at 24 h were 100%. Conclusions The ZeroVector® DL installation remained highly acceptable at 36-months post-installation, the material and fixtures proved durable and the efficacy against malaria vectors did not decrease. However, the DL material had been removed from over 50% of the original study homes 3 years post-installation, largely due to deteriorating housing infrastructure. Furthermore, the presence of the DL installation appeared to reduce ITN use among many participating householders. The study findings suggest DL may not be an appropriate vector control method for large-scale use in the contemporary PNG malaria control programme.
Collapse
Affiliation(s)
- Joseph J Kuadima
- Papua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea
| | - Lincoln Timinao
- Papua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea
| | - Laura Naidi
- Papua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea
| | - Anthony Tandrapah
- Papua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea
| | - Manuel W Hetzel
- Swiss Tropical and Public Health Institute, PO Box 4002, Basel, Switzerland.,University of Basel, Petersplatz 1, 4003, Basel, Switzerland
| | - Cyrille Czeher
- Papua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea
| | - Justin Pulford
- Papua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea. .,Liverpool School of Tropical Medicine, Liverpool, Pembroke Place, Liverpool, l35QA, UK.
| |
Collapse
|
6
|
Kweka EJ. Roles and challenges of construction firms and public health entomologists in ending indoor malaria transmission in African setting. Malar J 2016; 15:554. [PMID: 27842588 PMCID: PMC5109782 DOI: 10.1186/s12936-016-1607-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2016] [Accepted: 11/08/2016] [Indexed: 11/20/2022] Open
Abstract
Indoor malaria transmission reduction across sub-Saharan Africa has been attained through implementation of long-lasting insecticidal nets and indoor residual spray interventions with small-scale larval source management. Improvement of house structures in sub-Saharan Africa can lead to zero indoor malaria transmission with evidence from West Africa, East Africa and Middle East countries. Residual malaria transmission cannot be targeted well with LLINs and IRS alone, but with incorporation of house structures modifications it may be possible.
Collapse
Affiliation(s)
- Eliningaya J Kweka
- Division of Livestock and Human Diseases Vector Control, Tropical Pesticides Research Institute, P.O. Box 3024, Arusha, Tanzania. .,Department of Medical Parasitology and Entomology, Catholic University of Health and Allied Sciences, P.O. Box 1464, Mwanza, Tanzania.
| |
Collapse
|
7
|
Mtove G, Mugasa JP, Messenger LA, Malima RC, Mangesho P, Magogo F, Plucinski M, Hashimu R, Matowo J, Shepard D, Batengana B, Cook J, Emidi B, Halasa Y, Kaaya R, Kihombo A, Lindblade KA, Makenga G, Mpangala R, Mwambuli A, Mzava R, Mziray A, Olang G, Oxborough RM, Seif M, Sambu E, Samuels A, Sudi W, Thomas J, Weston S, Alilio M, Binkin N, Gimnig J, Kleinschmidt I, McElroy P, Moulton LH, Norris L, Ruebush T, Venkatesan M, Rowland M, Mosha FW, Kisinza WN. The effectiveness of non-pyrethroid insecticide-treated durable wall lining to control malaria in rural Tanzania: study protocol for a two-armed cluster randomized trial. BMC Public Health 2016; 16:633. [PMID: 27456339 PMCID: PMC4960851 DOI: 10.1186/s12889-016-3287-3] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2016] [Accepted: 07/09/2016] [Indexed: 11/16/2022] Open
Abstract
Background Despite considerable reductions in malaria achieved by scaling-up long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), maintaining sustained community protection remains operationally challenging. Increasing insecticide resistance also threatens to jeopardize the future of both strategies. Non-pyrethroid insecticidetreated wall lining (ITWL) may represent an alternate or complementary control method and a potential tool to manage insecticide resistance. To date no study has demonstrated whether ITWL can reduce malaria transmission nor provide additional protection beyond the current best practice of universal coverage (UC) of LLINs and prompt case management. Methods/design A two-arm cluster randomized controlled trial will be conducted in rural Tanzania to assess whether non-pyrethroid ITWL and UC of LLINs provide added protection against malaria infection in children, compared to UC of LLINs alone. Stratified randomization based on malaria prevalence will be used to select 22 village clusters per arm. All 44 clusters will receive LLINs and half will also have ITWL installed on interior house walls. Study children, aged 6 months to 11 years old, will be enrolled from each cluster and followed monthly to estimate cumulative incidence of malaria parasitaemia (primary endpoint), time to first malaria episode and prevalence of anaemia before and after intervention. Entomological inoculation rate will be estimated using indoor CDC light traps and outdoor tent traps followed by detection of Anopheles gambiae species, sporozoite infection, insecticide resistance and blood meal source. ITWL bioefficacy and durability will be monitored using WHO cone bioassays and household surveys, respectively. Social and cultural factors influencing community and household ITWL acceptability will be explored through focus-group discussions and in-depth interviews. Cost-effectiveness, compared between study arms, will be estimated per malaria case averted. Discussion This protocol describes the large-scale evaluation of a novel vector control product, designed to overcome some of the known limitations of existing methods. If ITWL is proven to be effective and durable under field conditions, it may warrant consideration for programmatic implementation, particularly in areas with long transmission seasons and where pyrethroid-resistant vectors predominate. Trial findings will provide crucial information for policy makers in Tanzania and other malaria-endemic countries to guide resource allocations for future control efforts. Trial registration NCT02533336 registered on 13 July 2014.
Collapse
Affiliation(s)
- George Mtove
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania.
| | - Joseph P Mugasa
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Louisa A Messenger
- Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
| | - Robert C Malima
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Peter Mangesho
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Franklin Magogo
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Mateusz Plucinski
- US President's Malaria Initiative, Atlanta, GA, USA.,Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Ramadhan Hashimu
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | | | - Donald Shepard
- National Institute for Medical Research, Headquarters, Dar es Salaam, Tanzania
| | - Bernard Batengana
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Jackie Cook
- Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
| | - Basiliana Emidi
- Kilimanjaro Christian Medical College, Moshi, Tanzania.,National Institute for Medical Research, Headquarters, Dar es Salaam, Tanzania
| | - Yara Halasa
- Brandeis University, Heller School, Waltham, Massachusetts, USA
| | - Robert Kaaya
- Kilimanjaro Christian Medical College, Moshi, Tanzania
| | - Aggrey Kihombo
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Kimberly A Lindblade
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Geofrey Makenga
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Robert Mpangala
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Abraham Mwambuli
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Ruth Mzava
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Abubakary Mziray
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - George Olang
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | | | - Mohammed Seif
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Edward Sambu
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - Aaron Samuels
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Wema Sudi
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| | - John Thomas
- Phoenix Ordinary LLC, Bridgewater, New Jersey, USA
| | - Sophie Weston
- Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
| | - Martin Alilio
- President's Malaria Initiative, United States Agency for International Development, Washington DC, USA
| | - Nancy Binkin
- Translating Research into Action Project (TRAction) University Research Co., LLC, Bethesda, Maryland, USA
| | - John Gimnig
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Immo Kleinschmidt
- Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
| | - Peter McElroy
- US President's Malaria Initiative, Atlanta, GA, USA.,Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Lawrence H Moulton
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Laura Norris
- President's Malaria Initiative, United States Agency for International Development, Washington DC, USA
| | - Trenton Ruebush
- Translating Research into Action Project (TRAction) University Research Co., LLC, Bethesda, Maryland, USA
| | - Meera Venkatesan
- President's Malaria Initiative, United States Agency for International Development, Washington DC, USA
| | - Mark Rowland
- Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
| | | | - William N Kisinza
- National Institute for Medical Research, Amani Research Centre, Muheza, Tanzania
| |
Collapse
|